<DOC>
	<DOCNO>NCT00678457</DOCNO>
	<brief_summary>This study would like test whether combination ondansetron olanzapine superior placebo decrease self-reported heavy drinking among early onset alcoholic .</brief_summary>
	<brief_title>Ondansetron With Olanzapine Treatment Alcohol Dependence : A Preliminary Clinical Trial</brief_title>
	<detailed_description>Target population : We enroll male female meet DSM IV criterion alcohol dependence currently drink equal 21 alcohol units/week woman equal 28 alcohol units/week men 7 day period prior enrollment . This double-blind placebo-controlled study . Eligible subject randomize ondansetron ( 4 ug/kg ) olanzapine ( 9 , 18 , 36 ug/kg ) v placebo . All subject participate 9 week regimen weekly BBCET outpatient medication treatment .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Males female give write informed consent Aged 18 year weigh ≥40 kg ≤140 kg Drinking average ≥21 ≥28 drinks/week woman men , respectively , 7day period prior enrollment DSMIVR diagnosis alcohol dependence Good physical health determine complete physical examination , electrocardiogram ( EKG ) within normal limit laboratory screen test within acceptable range Negative pregnancy test intake . Literate English able read , understand , complete rating scale questionnaires accurately , follow instruction , make use behavioral treatment Willing participate behavioral treatment alcoholism Answer advertisement newspaper/radio/television , express wish stop drinking Provide evidence stable residence last month prior enrollment study , plan move next three month Any current axis I DSMIV psychiatric disorder alcohol nicotine dependence warrant treatment would preclude safe participation protocol Severe alcohol withdrawal symptom , physician 's opinion , require inpatient treatment Serious medical comorbidity require medical intervention close supervision , condition interfere receipt ondansetron olanzapine Severe lifethreatening adverse reaction ondansetron olanzapine medication past clinical trial Female subject pregnant , lactating , adhere acceptable form contraception time study Received inpatient outpatient treatment alcohol dependence within last 30 day Significant medical illness ( include hypertension ) determine history and/or complete physical examination . Gross neurological disease Mental retardation Pyrexia unknown origin Diagnosis suspicion Alzheimer 's disease Clinically significant abnormality EKG preclude safe participation Recent ( last 3 month ) history ischemic heart disease myocardial infarction . Current infective hepatitis evidence clinical manifestation . If hepatitis suspect , hepatitis antibody/antigen screen do . Participation clinical study within last 30 day Elevation liver enzymes History severe lifethreatening reaction olanzapine ondansetron Past current history seizure disorder Past current history diabetes Being treat medication potential clinically significant interaction alcohol olanzapine and/or ondansetron . These include : , serotonin antagonist ( e.g. , ritanserin buspirone ) , dopamine antagonist ( e.g. , haloperidol ) , compound action similar disulfiram ( Antabuse® ) . Pending imprisonment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>alcohol dependence</keyword>
	<keyword>alcohol abuse</keyword>
	<keyword>drinking</keyword>
	<keyword>alcohol</keyword>
</DOC>